Longeveron Inc LGVN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
1.26quote price arrow down-0.02 (-1.56%)
Volume
4,893,873
Close
1.28quote price arrow down-0.01 (-0.78%)
Volume
232,595
52 week range
1.24 - 40.00
Loading...
  • Open1.31
  • Day High1.32
  • Day Low1.26
  • Prev Close1.29
  • 52 Week High40.00
  • 52 Week High Date06/16/23
  • 52 Week Low1.24
  • 52 Week Low Date05/13/24

Key Stats

  • Market Cap8.126M
  • Shares Out6.35M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.42
  • YTD % Change-90.59

KEY STATS

  • Open1.31
  • Day High1.32
  • Day Low1.26
  • Prev Close1.29
  • 52 Week High40.00
  • 52 Week High Date06/16/23
  • 52 Week Low1.24
  • 52 Week Low Date05/13/24
  • Market Cap8.126M
  • Shares Out6.35M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.42
  • YTD % Change-90.59

RATIOS/PROFITABILITY

  • EPS (TTM)-10.18
  • P/E (TTM)-0.13
  • Fwd P/E (NTM)-0.24
  • EBITDA (TTM)-19.893M
  • ROE (TTM)-163.05%
  • Revenue (TTM)708,999.991
  • Gross Margin (TTM)31.17%
  • Net Margin (TTM)-3,020.17%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/11/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Longeveron Inc

 

Profile

MORE
Longeveron Inc. is a clinical-stage biotechnology company. The Company is focused on developing cellular therapies for specific aging-related and life-threatening conditions. The Company's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors. The Company is primarily focused on three pipeline indications...
Joshua Hare M.D.
Chairman of the Board, Co-Founder, Chief Science Officer
Wa'el Hashad
Chief Executive Officer, Director
Lisa Locklear
Chief Financial Officer, Executive Vice President
Paul Lehr J.D.
General Counsel, Corporate Secretary, International Executive Director
Address
1951 NW 7th Ave, Ste 520
Miami, FL
33136
United States

Top Peers

SYMBOLLASTCHG%CHG
CANF
Can Fite Biopharma Ltd
2.38+0.14+6.37%
NTBL
Notable Labs Ltd
1.02-0.02-1.92%
BCDA
BioCardia Inc
0.392-0.0041-1.0351%
ATHE
Alterity Therapeutics Ltd
2.00-0.02-0.99%
SNGX
Soligenix Inc
0.3926+0.0026+0.6667%